000 01643 a2200457 4500
005 20250513031444.0
264 0 _c19950309
008 199503s 0 0 eng d
022 _a0007-0920
024 7 _a10.1038/bjc.1995.73
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchlumberger, M
245 0 0 _aTreatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC).
_h[electronic resource]
260 _bBritish journal of cancer
_cFeb 1995
300 _a363-5 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCarcinoma, Medullary
_xdrug therapy
650 0 4 _aCombined Modality Therapy
650 0 4 _aDacarbazine
_xadministration & dosage
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
650 0 4 _aPalliative Care
650 0 4 _aRadiotherapy, Adjuvant
650 0 4 _aStreptozocin
_xadministration & dosage
650 0 4 _aThyroid Neoplasms
_xdrug therapy
650 0 4 _aThyroidectomy
650 0 4 _aTreatment Outcome
700 1 _aAbdelmoumene, N
700 1 _aDelisle, M J
700 1 _aCouette, J E
773 0 _tBritish journal of cancer
_gvol. 71
_gno. 2
_gp. 363-5
856 4 0 _uhttps://doi.org/10.1038/bjc.1995.73
_zAvailable from publisher's website
999 _c7530447
_d7530447